Amory John Kenneth 4
4 · Clarus Therapeutics Holdings, Inc. · Filed Dec 14, 2021
Insider Transaction Report
Form 4
Amory John Kenneth
Director
Transactions
- Award
Common Stock
2021-12-12+3,844→ 3,844 total - Award
Stock Option (Right to Buy)
2021-12-12+9,610→ 9,610 totalExercise: $4.78Exp: 2031-12-11→ Common Stock (9,610 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 3,844 shares on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date.
- [F2]These options were granted under the 2021 Plan and vest in equal annual installments over a period of three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting.